Furthermore, researchers have engineered an AAV vector targeting the brain endothelium; it alters glioma vasculature through the expression of LIGHT protein and enhances T cell infiltration into tumor cells, providing a novel perspective for glioma treatment [135]. This evidence concerns the gene TNFSF14 and central nervous system cancer.